Literature DB >> 17707235

p73 suppresses polyploidy and aneuploidy in the absence of functional p53.

Flaminia Talos1, Alice Nemajerova, Elsa R Flores, Oleksi Petrenko, Ute M Moll.   

Abstract

Previous studies showed that p53 plays a central role in G1 and DNA damage checkpoints, thus contributing to genomic stability. We show here that p73 also plays a role in genomic integrity but this mechanism is manifest only when p53 is lost. Isolated p73 loss in primary cells does not induce genomic instability. Instead, it results in impaired proliferation and premature senescence due to compensatory activation of p53. Combined loss of p73 and p53 rescues these defects, but at the expense of exacerbated genomic instability. This leads to rapid increase in polyploidy and aneuploidy, markedly exceeding that of p53 loss alone. Constitutive deregulation of cyclin-Cdk activities and excess failure of the G2/M DNA damage checkpoint appear to fuel increased ploidy abnormalities upon p53/p73 loss, while primary mitotic defects do not play a causal role. These data indicate that p73 is essential for suppressing polyploidy and aneuploidy when p53 is inactivated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707235     DOI: 10.1016/j.molcel.2007.06.036

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis.

Authors:  F Talos; A Abraham; A V Vaseva; L Holembowski; S E Tsirka; A Scheel; D Bode; M Dobbelstein; W Brück; U M Moll
Journal:  Cell Death Differ       Date:  2010-12       Impact factor: 15.828

2.  Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.

Authors:  Xingming Chen; Erich M Sturgis; Adel K El-Naggar; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

3.  p73 - constitutively open for business.

Authors:  M A Seeliger; U M Moll
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

4.  Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.

Authors:  Erika Mikulenkova; Jakub Neradil; Karel Zitterbart; Jaroslav Sterba; Renata Veselska
Journal:  Tumour Biol       Date:  2015-04-25

5.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

Review 6.  Genome Stability Requires p53.

Authors:  Christine M Eischen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

7.  Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.

Authors:  Ali Zekri; Seyed H Ghaffari; Marjan Yaghmaie; Mehrdad Asghari Estiar; Kamran Alimoghaddam; Mohammad Hossein Modarressi; Ardeshir Ghavamzadeh
Journal:  Mol Neurobiol       Date:  2015-03-11       Impact factor: 5.590

8.  p63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells.

Authors:  M P Fatt; G I Cancino; F D Miller; D R Kaplan
Journal:  Cell Death Differ       Date:  2014-05-09       Impact factor: 15.828

9.  Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Authors:  Sebastian Kehrloesser; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Karen Heather Vousden; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

10.  Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.

Authors:  Vera Huang; Xin Lu; Yong Jiang; Jean Y J Wang
Journal:  BMC Biol       Date:  2009-06-26       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.